HealthCanal.com Half were given the drug pravastatin over five years and all the men were followed up for at least 15 years. This is the first time the cost-effectiveness of statins has been assessed in this way. The results showed that for every 1,000 patients who ...
Newstrack India Researchers noted that simvastatin and pravastatin , the generic names of the brands Zocor and Pravachol, were found to have the best safety profile in the class. This is particularly true when patients were prescribed low to moderate doses of those ...
Scotsman Half of the group were given the drug pravastatin and half a placebo over five years, and all the men were followed up for at least 15 years. The researchers said this was the first time the cost-effectiveness of statins has been assessed in this way ...
Herald Scotland The study was based on men aged between 45 and 64 who had high levels of cholesterol but no history of a heart attack. Half of the men, who were from the west of Scotland, were given pravastatin for five years and they were monitored for at least 15 years.
Express.co.uk A major study which followed 6,595 middle-aged men from the west of Scotland for 15 years found that those who took the cholesterol-lowering pravastatin drug were far less likely to need hospital treatment for heart disease and stroke. For every 1,000 ...
Glasgow Evening Times Half were given the drug pravastatin over five years and all the men were followed up for at least 15 years. The results showed that for every 1000 patients who received a 40mg dose of the drug once a day for five years, the NHS saved £710,000. There ...
Zee News They concluded "as a class, adverse events associated with statin therapy are not common." Researchers noted that simvastatin and pravastatin , the generic names of the brands Zocor and Pravachol, were found to have the best safety profile in the class.
Medscape SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin. ClinPharmacolTher. 2006;80:356–66. Cuisset T, Morange PE, Alessi MC. Recent advances in the pharmacogenetics of clopidogrel. Hum Genet. 2012;131:653–64.
Health.com In the analysis of 135 previous studies, which included nearly 250,000 people combined, researchers found that the drugs simvastatin (Zocor) and pravastatin (Pravachol) had the fewest side effects in this class of medications. They also found that ...
